 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Associate Professor of Psychiatry and Behavioral Neurosciences and Department of Obstetrics and Gynecology McMaster University, Hamilton, Ontario, Canada Academic Head, Mood Disorders Division, McMaster University
Director, Women’s Health Concerns Clinic St. Joseph’s Healthcare & McMaster University
Fontbonne Building, 6th Floor
Claudio N Soares,
MD, PhD, FRCPC is an Associate Professor in the Depts. of Psychiatry
and Behavioral Neurosciences and Obstetrics & Gynecology at McMaster
University, Hamilton, Ontario, where he is also the Academic Head of
the Mood Disorders Division and Director of the Women’s Health
Concerns Clinic (WHCC) at St. Joseph’s Healthcare Hamilton.Dr.
Soares is a psychiatrist who earned his medical degree (1989,
completed his residency training (1994) and later earned his PhD in
Psychoneuroendocrinology (1998) from the University of Sao Paulo
Medical School, in Brazil. During his tenure at the University of
Sao Paulo, Dr. Soares implemented the first outpatient clinic in
Brazil that was exclusively devoted to clinical, research and
educational activities in women’s mental health. His postdoctoral
fellowship in Perinatal and Reproductive Psychiatry was completed in
2001 at the Massachusetts General Hospital (MGH), Harvard Medical
School (HMS). He continued to work as an Assistant Professor of
Psychiatry at HMS and Director of Research of the Perinatal and
Reproductive Psychiatry group at MGH until joining McMaster
University in 2005. Dr. Soares’ research career has been focused on mood and anxiety disturbances across the female reproductive life cycle (e.g., premenstrual events, pregnancy/ postpartum, menopausal transition). His primary research focus has been on the relative contribution of changes/fluctuations in gonadal steroids for the development of female-specific psychiatric disorders (i.e., ‘windows of vulnerability’) and the development of hormonal and non-hormonal treatment strategies for depression and other complaints during the menopausal transition. His most recent research is focused on immune and psychiatric disturbances among female immigrants and their offspring. Dr. Soares is a sought after educator and speaker both nationally and internationally. He is a member of various psychiatric and menopause-related medical societies (APA, CCNP, NAMS) and recipient of numerous honors and awards, including the North American Society for Psychosocial Obstetrics and Gynecology (NASPOG) Award, and 3 National Alliance for Research on Schizophrenia and Depression (NARSAD) awards. He has written extensively in the areas of mood disorders and women’s mental health, with more than 140 publications (peer-reviewed manuscripts, books, book chapters and abstracts). His articles are published in Archives of General Psychiatry, Journal of Affective Disorders, Journal of Clinical Psychiatry, American Journal of Psychiatry and Menopause, to name a few. He serves as Co-Editor-in-Chief of the Archives of Women’s Mental Health and is member of the Editorial Board the Menopause (the North American Menopause Society – NAMS - official journal). From 2006 to 2009, he contributed as Associate Editor for the Journal Watch Women’s Health –from the publishers of the New England Journal of Medicine.
Selected Publications: Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A Randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2001; 58:529-34. Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Lifetime History of Depression and its Influence on Reproductive Endocrine and Menstrual Cycle Markers Associated with the Perimenopause - The Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2003; 60:29-36. Cohen LS, Soares CN, Poitras JR, Alexander AB, Shifren JL. Short-term Use of Estradiol for Depression in Perimenopausal and Postmenopausal Women: a Preliminary Report. Am J Psychiatry 2003; 160: 1519-1522. Soares CN, Poitras JR, Shifren JL, Alexander AB. Efficacy of Citalopram as a Monotherapy or as an Adjunctive Treatment for Perimenopausal and Postmenopausal Women with Depression and Vasomotor Symptoms. J Clin Psychiatry 2003; 64:473-479. Cohen LS, Soares CN, Lyster A, Cassano P, Brandes M, LeBlanc GA. Intermittent Use of Venlafaxine for the Treatment of Premenstrual Dysphoric Disorder (PMDD). J Clin Psychopharmacol 2004; 24(5):540-3. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: Harvard study of moods and cycles. Arch Gen Psychiatry. 2006; 63(4): 385-90. Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS. Escitalopram versus Ethinyl Estradiol and Norethindrone Acetate for Symptomatic Peri and Postmenopausal Women: Impact on Depression, Vasomotor Symptoms, Sleep, and Quality of Life. Menopause, 2006; 13(5):780-6. Soares CN, Joffe H, Arsenio H, Petrillo L, Viguera AC, Cohen, LS. Paroxetine CR for the treatment of mood and menopause-related symptoms after hormonal discontinuation. Am J Med. 2008; 121(2):159-162. Soares CN, Zitek B. Reproductive Hormone Sensitivity and Risk for Depression across the Female Life Cycle: a Continuum of Vulnerability? J Psychiatry Neurosci. 2008; 33(4):331-43. Soares CN, Kornstein SG, Thase ME, Jiang Q, Guico-Pabia CJ. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials. J Clin Psychiatry. 2009;70(10):1365-71
|
